Loading clinical trials...
Loading clinical trials...
This study will evaluate the safety and efficacy of onabotulinumtoxinA (BOTOX®) compared with placebo as treatment for major depressive disorder (MDD) in adult females.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Allergan
NCT07227454 · Depressive Disorder, Major
NCT06860958 · Depressive Disorder, Major
NCT06546917 · Depressive Disorder, Major, Cognitive Dysfunction
NCT07412756 · Depressive Disorder, Major
NCT06152705 · Depression, Depressive Disorder, Major, and more
Woodland International Research Group
Little Rock, Alaska
CITrials
Bellflower, California
Radiant Research/Comprehensive Clinical Development, Inc.
Cerritos, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions